CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rackley, R. R.
Right arrow Articles by Williams, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rackley, R. R.
Right arrow Articles by Williams, B. R.

Cell Growth & Differentiation, Vol 4, Issue 12 1023-1031, Copyright © 1993 by American Association of Cancer Research


ARTICLES

Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis

RR Rackley, AM Flenniken, NP Kuriyan, PM Kessler, MH Stoler and BR Williams
Department of Cancer Biology, Cleveland Clinic Foundation, Ohio 44195-5001.

WT1 is a Wilms' tumor suppressor gene that maps to human chromosome 11p13 and encodes a putative transcription factor implicated in controlling normal urogenital development. Sporadic homozygous mutations in WT1 result in the development of Wilms' tumor (nephroblastoma), and heterozygous germline mutations can give rise to a phenotype which includes nephropathy and urogenital abnormalities (the Denys-Drash syndrome). Thus, inappropriate expression of WT1 results in developmental abnormalities affecting the urogenital system. To better define the temporal and spatial distribution of WT1 expression during embryogenesis, we have used in situ mRNA hybridization and immunohistochemistry to examine WT1 expression in murine embryos during the period prior to and throughout active organogenesis. Prior to embryological day 9.5 (E9.5), WT1 mRNA expression is absent in the embryo proper but is strongly expressed in the maternal uterus. During the initiation of organogenesis on E10.5, WT1 mRNA is localized within the pronephric and mesonephric tissues. By E11.5, the nephrogenic cord, urogenital ridge, and condensing metanephric tissue show intense WT1 hybridization signals, and increasingly centripetal expression of WT1 in the kidney correlates with renal differentiation from days E11.5 through E16.5. The stromal cell components in the developing gonad show expression of WT1 by E10.5, whereas in the remaining organs examined, WT1 expression is restricted to the uterus, spleen, abdominal wall musculature, and mesothelial lining of organs within the thoracic and abdominal cavities. Interestingly, there is also WT1 expression in the central nervous system which localizes to the ependymal layer of the ventral aspect of the spinal cord.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
Q. Wen, Q.-S. Zheng, X.-X. Li, Z.-Y. Hu, F. Gao, C. Y. Cheng, and Y.-X. Liu
Wt1 dictates the fate of fetal and adult Leydig cells during development in the mouse testis
Am J Physiol Endocrinol Metab, December 15, 2014; 307(12): E1131 - E1143.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
F. Bollig, B. Perner, B. Besenbeck, S. Kothe, C. Ebert, S. Taudien, and C. Englert
A highly conserved retinoic acid responsive element controls wt1a expression in the zebrafish pronephros
Development, September 1, 2009; 136(17): 2883 - 2892.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. Boyer, L. Hermo, M. Paquet, B. Robaire, and D. Boerboom
Seminiferous Tubule Degeneration and Infertility in Mice with Sustained Activation of WNT/CTNNB1 Signaling in Sertoli Cells
Biol Reprod, September 1, 2008; 79(3): 475 - 485.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Klattig, R. Sierig, D. Kruspe, B. Besenbeck, and C. Englert
Wilms' Tumor Protein Wt1 Is an Activator of the Anti-Mullerian Hormone Receptor Gene Amhr2
Mol. Cell. Biol., June 15, 2007; 27(12): 4355 - 4364.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. M. Kirschner, N. Wagner, K.-D. Wagner, S. Wellmann, and H. Scholz
The Wilms Tumor Suppressor Wt1 Promotes Cell Adhesion through Transcriptional Activation of the {alpha}4integrin Gene
J. Biol. Chem., October 20, 2006; 281(42): 31930 - 31939.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Dame, K. M. Kirschner, K. V. Bartz, T. Wallach, C. S. Hussels, and H. Scholz
Wilms tumor suppressor, Wt1, is a transcriptional activator of the erythropoietin gene
Blood, June 1, 2006; 107(11): 4282 - 4290.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
A. Brendolan, E. Ferretti, V. Salsi, K. Moses, S. Quaggin, F. Blasi, M. L. Cleary, and L. Selleri
A Pbx1-dependent genetic and transcriptional network regulates spleen ontogeny
Development, July 1, 2005; 132(13): 3113 - 3126.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. S. Orloff, S. K. Iyengar, C. A. Winkler, K. A. B. Goddard, R. A. Dart, T. S. Ahuja, M. Mokrzycki, W. A. Briggs, S. M. Korbet, P. L. Kimmel, et al.
Variants in the Wilms tumor gene are associated with focal segmental glomerulosclerosis in the African American population
Physiol Genomics, April 1, 2005; 21(2): 212 - 221.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
N. Wagner, K.-D. Wagner, A. Hammes, K. M. Kirschner, V. P. Vidal, A. Schedl, and H. Scholz
A splice variant of the Wilms' tumour suppressor Wt1 is required for normal development of the olfactory system
Development, March 15, 2005; 132(6): 1327 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. Renshaw, R. M. Orr, M. I. Walton, R. te Poele, R. D. Williams, E. V. Wancewicz, B. P. Monia, P. Workman, and K. Pritchard-Jones
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: Antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival
Mol. Cancer Ther., November 1, 2004; 3(11): 1467 - 1484.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. T. Discenza and J. Pelletier
Insights into the physiological role of WT1 from studies of genetically modified mice
Physiol Genomics, February 1, 2004; 16(3): 287 - 300.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
K.-D. Wagner, N. Wagner, V. P. I. Vidal, G. Schley, D. Wilhelm, A. Schedl, C. Englert, and H. Scholz
The Wilms' tumor gene Wt1 is required for normal development of the retina
EMBO J., March 15, 2002; 21(6): 1398 - 1405.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
Z. Sun and N. Hopkins
vhnf1, the MODY5 and familial GCKD-associated gene, regulates regional specification of the zebrafish gut, pronephros, and hindbrain
Genes & Dev., December 1, 2001; 15(23): 3217 - 3229.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
T. H. LEE and J. PELLETIER
Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter
Physiol Genomics, December 1, 2001; 7(2): 187 - 200.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
L. Gnessi, S. Basciani, S. Mariani, M. Arizzi, G. Spera, C. Wang, C. Bondjers, L. Karlsson, and C. Betsholtz
Leydig Cell Loss and Spermatogenic Arrest in Platelet-Derived Growth Factor (Pdgf)-a-Deficient Mice
J. Cell Biol., May 29, 2000; 149(5): 1019 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
V. Scharnhorst, P. Dekker, A. J. van der Eb, and A. G. Jochemsen
Physical Interaction between Wilms Tumor 1 and p73 Proteins Modulates Their Functions
J. Biol. Chem., April 7, 2000; 275(14): 10202 - 10211.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Kim, D. Prawitt, N. Bardeesy, E. Torban, C. Vicaner, P. Goodyer, B. Zabel, and J. Pelletier
The Wilms' Tumor Suppressor Gene (wt1) Product Regulates Dax-1 Gene Expression during Gonadal Differentiation
Mol. Cell. Biol., March 1, 1999; 19(3): 2289 - 2299.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Bergmann, C. Miething, U. Maurer, J. Brieger, T. Karakas, E. Weidmann, and D. Hoelzer
High Levels of Wilms' Tumor Gene (wt1) mRNA in Acute Myeloid Leukemias Are Associated With a Worse Long-Term Outcome
Blood, August 1, 1997; 90(3): 1217 - 1225.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
H. T. Cohen, S. A. Bossone, G. Zhu, G. A. McDonald, and V. P. Sukhatme
Sp1 Is a Critical Regulator of the Wilms' tumor-1 Gene
J. Biol. Chem., January 31, 1997; 272(5): 2901 - 2913.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. Ernstsson, S. Pierrou, M. Hulander, A. Cederberg, M. Hellqvist, P. Carlsson, and S. Enerback
Characterization of the Human Forkhead Gene FREAC-4: EVIDENCE FOR REGULATION BY WILMS' TUMOR SUPPRESSOR GENE (WT-1) AND p53
J. Biol. Chem., August 30, 1996; 271(35): 21094 - 21099.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
W. Bruening and J. Pelletier
A Non-AUG Translational Initiation Event Generates Novel WT1 Isoforms
J. Biol. Chem., April 12, 1996; 271(15): 8646 - 8654.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1993 by the American Association of Cancer Research.